News
Bayer gets €3bn from Apollo for contraceptives unit stake
Bayer has partnered with private equity group Apollo to set up a new entity that will handle its long-acting contraceptives products.
News
Moderna's mResvia gets shot in the arm from EU contract
A new EU procurement contract could give Moderna's RSV shot mResvia, which has struggled to gain traction in the market, a welcome boost.
News
Keenova eyes Xiaflex as first drug for plantar fibromatosis
Keenova is hoping that its Xiaflex drug can become the first approved therapy for plantar fibromatosis, a debilitating condition affecting the feet.
Sales & Marketing
Is pure play pharma's new pharmakon?
The shift in commercial teams has been happening for some time. This is not new news. I have felt it many times over, like many of us who have worked in the industry for years.
News
AZ, Ionis hit by unexpected Wainua trial failure
Prospects for AstraZeneca and Ionis' Wainua have been severely dented by a failed trial in ATTR cardiomyopathy, weighing on the shares of both firms.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
